Antaros Medical, in collaboration with Sahlgrenska University Hospital and AstraZeneca, are presenting new promising data during the 56th ERA-EDTA congress taking place in Budapest, June 13-16, 2019. Three posters are presented showing different aspects of magnetic resonance imaging (MRI) as a non-invasive tool that increases precision, sensitivity and repeatability for drug development in chronic kidney disease (CKD).
FP491:
Presenter: Adjunct Professor Paul Hockings, Antaros Medical
Authors: Kianoush Makvandi, Gert Jensen, Paul Hockings, Tim Unnerstall, Henrik Leonhardt, Lisa Jarl, Anna Frödén Löwenmark, Camilla Englund, Susan Francis, Fredrik Erlandsson, Anna K Sundgren, Johannes Hulthe, Seema Baid-Agrawal
FP512:
MR imaging biomarkers of Diabetic Kidney Disease
Presenter: Adjunct Professor Paul Hockings, Antaros Medical
Author: Paul Hockings, Kianoush Makvandi, Tim Unnerstall, Henrik Leonhardt, Anna Frödén Löwenmark , Lisa Jarl, Camilla Englund, Susan Francis, Gert Jensen, Fredrik Erlandsson, Anna K Sundgren, Johannes Hulthe, Seema Baid-Agrawal
FP494:
Magnetic Resonance Imagining Biomarkers correlate to UACR in Diabetic Kidney Disease
Presenter:
Author: Kianoush Makvandi, Gert Jensen, Paul Hockings, Tim Unnerstall, Henrik Leonhardt, Lisa Jarl, Anna Frödén Löwenmark, Camilla Englund, Susan Francis, Fredrik Erlandsson, Anna K Sundgren, Johannes Hulthe, Seema Baid-Agrawal